![](https://www.hcrx.com/wp-content/uploads/2017/08/HealthCare-Royalty_eligard.png)
Astellas Europe
Royalty Monetization$18 Million
Jun 2012
MarketerAstellas Europe
ELIGARD® is a prescription drug used to manage the symptoms of advanced prostate cancer. Eligard is an LHRH (luteinizing hormone-releasing hormone) agonist and is designed to reduce the amount of testosterone in the body by reducing the testicles’ production of testosterone.